CAS RN: 1133706-15-6

Bortezomib-d5

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250519 5mg Out of stock 30 business days Inquiry
  • Product code: starshine_CAS1133706-15-6
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1133706-15-6 / [(1R)-3-methyl-1-[[(2S)-3-(2,3,4,5,6-pentadeuteriophenyl)-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid

[3-methyl-1-[[3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid | [3-methyl-1-[[1-oxo-2-[[oxo(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid | (3-Methyl-1-(3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid

Standard CAS: 1133706-15-6 Multi CAS: Yes

Basic Information

CAS
1133706-15-6
Multi CAS
Yes
Molecular Formula
C19H25BN4O4
Molecular Weight
389.300000
Exact Mass
389.228269
SMILES
[2H]C1=C(C(=C(C(=C1[2H])[2H])C[C@@H](C(=O)N[C@H](B(O)O)CC(C)C)NC(=O)C2=NC=CN=C2)[2H])[2H]
InChI
InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1/i3D,4D,5D,6D,7D
InChIKey
GXJABQQUPOEUTA-QAOZPTLUSA-N
Synonyms
[3-methyl-1-[[3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid [3-methyl-1-[[1-oxo-2-[[oxo(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid (3-Methyl-1-(3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid Bortezomib Impurity Ps619 SCHEMBL466239

Computed Properties

Structural Parameters

Heavy atom count
28
Aromatic heavy atom count
12
Fraction Csp3
0.37
Rotatable bonds
9
H-bond acceptors
6
H-bond donors
4
Molar refractivity
105.01
TPSA
124.44

LogP / Solubility

WLOGP
0.36
MLOGP
0.34
XLogP3
0.36
Consensus LogP
0.35
Log S (ESOL)
-2.17
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.97
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-3.54
Class (SILICOS-IT)
Poorly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.81

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3.5

Get In Touch

Contact Us